Form 4: Marimed COO Timothy Shaw Reports Stock Transactions
SEC Form 4 Filing
Timothy Shaw, Chief Operating Officer of Marimed Inc., reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On September 1, 2024, Timothy Shaw, the Chief Operating Officer of Marimed Inc., had 130,000 Restricted Stock Units (RSUs) vest, which converted into common stock on a one-for-one basis.
- The company withheld 38,156 shares of common stock at a price of $0.1855 to satisfy tax withholding obligations related to the RSU vesting.
- Following these transactions, Shaw directly owns 8,639,822 shares of common stock and indirectly owns 2,000,000 shares through the Shaw Family Trust.
- The RSUs were granted on September 1, 2023, and vest in installments through September 1, 2026.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The vesting of RSUs aligns executive interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 09/01/2023 | RSUs were granted |
| 09/01/2024 | RSUs vested and shares withheld for taxes |
| 09/04/2024 | Date of Form 4 filing |
| 09/01/2026 | Final vesting date for remaining RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.